Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

Related Articles
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the burden COPD places on society.
Leonard Nimoy’s recent death from end-stage chronic obstructive pulmonary disease (COPD) brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter.
With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$